Moderna
MRNA
$129.06
Share price
0.58%
Change (1 day)
-0.92%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.
Moderna (MRNA) - Cash on Hand
Cash on Hand as of March 2024 : $8.52 B
According to Moderna
's latest financial reports the company has $8.52 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Moderna - Cash on Hand chart (from 2017 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $8.60 B | -13.11% |
| 2022-12-31 | $9.90 B | -7.69% |
| 2021-12-31 | $10.72 B | 132.79% |
| 2020-12-31 | $4.60 B | 317.77% |
| 2019-12-31 | $1.10 B | -27.5% |
| 2018-12-31 | $1.52 B | 101.24% |
| 2017-12-31 | $0.75 B | -28.55% |
| 2016-12-31 | $1.05 B |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $26.21 B | 207.61% | 🇺🇸 USA |
 Novartis NVS | $9.69 B | 13.74% | 🇨🇭 Switzerland |
 Merck MRK | $7.09 B | -16.78% | 🇺🇸 USA |
 Regulus Therapeutics RGLS | $23.76 M | -99.72% | 🇺🇸 USA |
 Dicerna Pharmaceuticals DRNA | N/A | N/A | 🇺🇸 USA |
 Athersys ATHX | $1.02 M | -99.99% | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | $2.37 B | -72.18% | 🇺🇸 USA |
 Arrowhead Pharmaceuticals
ARWR | $0.22 B | -97.42% | 🇺🇸 USA |